Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 15/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

40%

2 trials in Phase 3/4

Results Transparency

50%

2 of 4 completed trials have results

Key Signals

2 with results

Enrollment Performance

Analytics

Phase 4
2(100.0%)
2Total
Phase 4(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT04109352Unknown

Labelled Carbon Sucrose Breath Test (13C-SBT) as a Marker of Environmental Enteropathy

Role: collaborator

NCT02661750Completed

Safety and Efficacy of High Dose Bowel Preparation Solutions for Patients With Difficult To Clean Colons For Colonoscopy

Role: lead

NCT01635725Completed

New Bowel Preparation Scale for Measuring Colon Cleanliness

Role: lead

NCT01719653Phase 4Completed

A Comparison of 5 Low Volume Bowel Preparations

Role: lead

NCT01063049Phase 4Completed

Gatorade/Miralax With or Without Bisacodyl Versus NuLytely for Colonoscopy Preparation

Role: lead

All 5 trials loaded